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Abstract

The inability of current mass spectrometry techniques to differentiate phospholipid isomers results in a
routine under-estimation of phospholipid molecular diversity in complex biological matrices. Recent
technological advances in tandem mass spectrometry and ion activation are helping to overcome these
limitations, but all rely on tandem mass spectrometry with unit mass-selection and suffer from co-isolation of
isobaric or isomeric species. Accordingly, separation of phospholipid isomers and isobars prior to
characterization is required to fully delve into the complexity of the lipidome. Here we present a novel twostage workflow combining reversed-phase ultra-high performance liquid chromatography with ozone-induced
dissociation (OzID) and combined-collision- and ozone-induced-dissociation (COzID) that reduces spectral
complexity and enables discrimination of lipid isomers and isobars. Application of this technique to the
analysis of human red blood cell lipid extracts allowed the separation, or partial separation, of adduct ion and
head group isobars as well as double bond and sn-positional isomers affording near complete structural
characterization of low abundance lipids, e.g. PC 18:0/20:3(n-6), PS 18:0/20:4(n-6) and PS 20:4(n-6)/18:0
all observed at m/z 834.7. We also introduce a software plug-in that automatically annotates OzID mass
spectra to assign the carbon-carbon double bond positions in lipids. This new workflow allows us to delve
deeper into the lipidome and represents another valuable tool for the lipidomics toolbox.
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ab s t r a c t
The inability of current mass spectrometry techniques to differentiate phospholipid isomers results in
a routine under-estimation of phospholipid molecular diversity in complex biological matrices. Recent
technological advances in tandem mass spectrometry and ion activation are helping to overcome these
limitations, but all rely on tandem mass spectrometry with unit mass-selection and suffer from coisolation of isobaric or isomeric species. Accordingly, separation of phospholipid isomers and isobars
prior to characterization is required to fully delve into the complexity of the lipidome. Here we present
a novel two-stage workﬂow combining reversed-phase ultra-high performance liquid chromatography with ozone-induced dissociation (OzID) and combined-collision- and ozone-induced-dissociation
(COzID) that reduces spectral complexity and enables discrimination of lipid isomers and isobars. Application of this technique to the analysis of human red blood cell lipid extracts allowed the separation, or
partial separation, of adduct ion and head group isobars as well as double bond and sn-positional isomers
affording near complete structural characterization of low abundance lipids, e.g. PC 18:0/20:3(n-6), PS
18:0/20:4(n-6) and PS 20:4(n-6)/18:0 all observed at m/z 834.7. We also introduce a software plug-in
that automatically annotates OzID mass spectra to assign the carbon–carbon double bond positions in
lipids. This new workﬂow allows us to delve deeper into the lipidome and represents another valuable
tool for the lipidomics toolbox.
Crown Copyright © 2018 Published by Elsevier B.V. All rights reserved.

1. Introduction
Lipids play important roles in cellular structure and function
and understanding these dynamic interactions is a critical focus of
the ﬁeld of lipidomics. Critical to such investigations has been the
desire to establish a baseline understanding of what constitutes
a lipidome for a particular cell or organism. That is, how many
lipids are present and what is their absolute or relative concentration? This seemingly straightforward ambition is challenged by
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the large differences in concentration of different lipid components
and the sheer molecular diversity of lipids; with estimates ranging from several hundred to several hundred thousand individual
molecular components [1–3].Focusing on phospholipids alone, the
high potential of isobaric and isomeric overlap between individual lipids is due in part to the numerous combinations of different
headgroups and fatty acids that vary in chain length, number and
position of double bonds, position of substitution on the glycerol
backbone and stereochemistry. These combinations give rise to
extensive chemical diversity of biological lipidomes and highlight
the challenges in differentiating and uniquely identifying lipids in
contemporary workﬂows [4–9].
Recent advances in mass spectrometry have provided powerful new tools to address the challenges of structural lipidomics
[6,10,11]. In particular, enhancements in sensitivity, mass resolving power, speed of analysis, and multi-stage fragmentation have
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enabled the development of protocols for identiﬁcation and quantiﬁcation of hundreds of lipid species per sample [6,11]. In a
recent example, a combination of high resolution mass analysis
and collision-induced dissociation (CID) afforded the identiﬁcation
of 300 lipids in one sample [10]. However, even such advanced
instrumentation can be limited in resolution of closely spaced isobars and discrimination of lipid isomers [4]. This ultimately limits
the molecular description of the lipids and thus the complexity of
the lipidome is not fully described. In response, additional mass
spectrometric methods aimed at differentiating lipid isomers have
evolved; largely targeting double bond positional isomers and snregioisomers. These include, ozone-induced dissociation (OzID)
[8,12,13] alone or coupled with CID [14], electron-induced dissociation (EID) [15], the Patterno-Buchi reaction; [16] and UVPD
[17]. The advantages and limitations of these new generation technologies have been recently reviewed [7] but all rely on tandem
mass spectrometry with unit mass-selection and can thus suffer
from complexity arising from co-isolation of isobaric or isomeric
species. Taken together, the aforementioned methods are capable of addressing speciﬁc questionsin the characterization of lipid
structures; however, no one technology in isolation is yet capable
of fully unravelling the molecular complexity of the lipidome [7].
Chromatographic or mobility-based separations [18] used
in conjunction with new ion activation approaches may offer
solutions to the full description of the lipidome. Previously we
have demonstrated proof-of-principle protocols combining liquid
chromatography (LC) separations with ozone-induced dissociation
workﬂows [19–21]. These approaches were successful in affording
partial separation and unique identiﬁcation of glycerophospholipid
isomers in mixtures of synthetic lipids, but were less successful
when applied to biological lipid extracts [19,20]. To this point
however, complicated lipid mixtures have not been thoroughly
examined and the full beneﬁts of chromatographic separations
to spectral complexity have not previously been demonstrated.
Here, we expand and improve the information that can be gained
from LC-OzID workﬂows and introduce a hybrid protocol we term,
combined-collision- and ozone-induced dissociation (COzID),
that affords information on both double-bond and sn-position in
glycerophospholipids. Furthermore, we introduce the application
of a novel software plug-in for automating OzID-mass spectral
annotations.
The lipidome ofhuman red blood cells (RBC) haspreviously been
discussed as a model system to explore lipid structural diversity
[5]. Despite numerous studies however, a full description of even
the phosphatidylcholine (PC) class remains elusive [22–25]. Understanding the baseline complexity of human RBC can have wide
reaching importance as these cells are widely analyzed as carriers of possible lipid biomarkers in clinical studies [26–28]. While a
comprehensive study of the full RBC lipidome is beyond the scope
of the present investigation it provides an excellenttarget for establishing the performance of our protocols for the discrimination
and identiﬁcation of isomeric and isobaric lipids in a cellular lipid
extract.

2. Methods
2.1. Materials
All solvents used, including water, were LC–MS grade and
purchased from VWR Inc (Tingalpa, QLD, Australia). Butylated hydroxytoluene (BHT) was purchased from Sigma-Aldrich
(Castle Hill, NSW, Australia). Ammonium acetate and sodium
acetate (analytical grade) were purchased from Ajax Chemicals
(Auburn, NSW, Australia). Industrial-grade compressed oxygen
with 0.5% nitrogen was obtained from BOC (Cringila, NSW,

Australia). Synthetic phospholipids; 1,2-di-(9Z-octadecenoyl)-snglycero-3-phosphocholine (PC 18:1(n-9)/18:1(n-9)), 1,2-di-(6Zpetroselinoyl)-sn-glycero-3-phosphocholine
(PC
18:1(n12)/18:1(n-12)), 1-octadecanoyl-2-(9Z,12Z-octadecadienoyl)-snglycerol-3-phosphocholine (PC
18:0/18:2(n-6,n-9)), 1-(9Zoctadecenoyl)-2-octadecanoyl-sn-glycero-3-phosphocholine
(PC 18:1(n-9)/18:0) and 1-octadecanoyl-2-(9Z-octadecenoyl)sn-glycero-3-phosphocholine (PC 18:0/18:1(n-9)) were acquired
from Avanti Polar Lipids (Alabaster, Alabama, USA).
2.2. Lipid extraction
Blood samples were collected from human subjects in accordance with predeﬁned biobanking standards at the University of
Wollongong and ethics approval was obtained from the University of Wollongong Human Ethics Research Committee (HE16/016
& HE16/018). Lipid extraction from human red blood cells followed
the methyl tert-butyl ether (MTBE) protocol of Matyash et al. [29]
that was adapted toa liquid handling workstation (Hamilton STAR,
Reno, NV, USA) [30]. In brief, 290 Lof aqueous ammonium acetate
(150 mM with 2 mM EDTA) was added to the wells of a 2.0 mL, 96well plate cooled on ice. A 10 L aliquot of packed red blood cells
was added to each well before the plate was vortexed at 800 rpm
for 10 mins. Sample plates, solvents and reagents were loaded onto
the liquid handling workstation where the following steps were
performed. First, 300 L of methanol was added and the sample
mixed prior to standing for 10 mins. Next, 1000 L of MTBE was
added to the samples and mixed for 30 mins before the mixture
was allowed to stand for 15 mins toallow phase separation. Following this, 500 L of the MTBE topphase was removed,placed in glass
vials with Teﬂon caps andstored at −20 ◦ C until mass spectrometric
analysis.
2.3. Sample preparation
2.3.1. Direct infusion mass spectrometry
For direct infusion experiments, RBC lipid extracts were diluted
1:50 in methanol containing 1 M sodium acetate. Mass spectra
were acquired using a hybrid triple quadrupole linear ion-trap mass
®
spectrometer (QTRAP5500 system, SCIEX, Concord, ON, Canada)
previously modiﬁed to incorporate ozone, generated online by an
ozone generator (Titan, Absolute Ozone, Alberta, Canada), into the
nitrogen collision gas line [12,31]. For direct infusion experiments,
diluted lipid extracts were infused at a ﬂow rate of 3 L min−1
through an ESI source in positive mode. Typical source settings
were: 5500 V ion spray voltage; source temperature 250 ◦ C; 100 V
de-clustering potential; 10 V for the entrance potential; nitrogen
serving as the nebulizing gas at 20 psi; curtain gas 10 psi; and
auxiliary gas 20 psi. Typical OzID experimental conditions utilized an oxygen ﬂow rate through the generator of 250 mL min−1
with the ozone generator power output at 40% to obtain approximately 220 g Nm−3 of ozone (ca. 15% v/v ozone in oxygen). The
gas ﬂow from the generator was split to direct the majority of the
ﬂow through an ozone destruct catalyst (IN USA, Norwood, MA,
USA). The remainder was passed through a variable leak valve (VSE
Vacuum Technology, Lustenau, Austria) for regulating ozone (in
oxygen) introduction into the collision cell (q2 ) via the nitrogen
collision gas line. An external ambient ozone monitor (Mini-HiCon,
IN USA, Norwood, MA, USA) was interlocked to the remote shut-off
on the generator and set to disable ozone production if the ambient ozone concentration rose above 60 ppb. All experiments were
®
controlled and data acquired using Analyst software (SCIEX, Concord, ON, Canada). Direct infusion COzID spectra were acquired by
mass selecting precursor ions in the ﬁrst quadrupole (q1) with an
isolation width of 1 Th and accelerating them into q 2 with collision
energy of 37 eV. Ions were trapped in the presence of ozone in q2
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for 4000 ms. Product ions were then transferred with a post collision energy of 8 eV and measured in the linear ion trap (q 3 ) with
a ﬁll time of 500 ms. Direct infusion spectra are reported here as
a summation of 200 cycles (∼17.9 mins of spectral acquisition as
calculated by Analyst software).
2.3.2. Liquid-chromatography mass spectrometry
For liquid chromatography, a pooled sample from at least
5 different individual RBC lipid extracts was prepared. 200 L
aliquots from the pooled extract were dried down and reconstituted in 200 L methanol prior to analysis Reversed-phase
ultra-high performance liquid chromatography (RP-UHPLC)
runs were performed using an UHPLC system (ACQUITY UPLC,
Waters, Milford, Massachusetts, USA) ﬁtted with a C30 column
(Acclaim 2.1 × 150 mm, 3 m particle size, Thermo Fisher Scientiﬁc, Scoresby, VIC, Australia) held at 25 ◦ C. Two mobile phases
were used; A: 5 mM ammonium acetate in water, and B: 5 mM
ammonium acetate in methanol/acetonitrile (60/40 v/v). The gradient used was 12.5% A to 100% B in 25 min, hold from 25 to 30 min
at 100% B, return to 12.5% A over 1 min followed by equilibration
for an additional 9 min. For LC–MS operation, 5 L of sample was
injected on column with a solvent ﬂow rate of 500 L min−1.
Sodium acetate (0.5 mM) was infused into the ﬂow path prior to
the ESI source using a T-junction at a rate of 15 L min−1 . Ion spray
voltage was 5500V, declustering potential 90 V, entrance potential
8 V and source temperature set to 400 ◦ C. Nitrogen was used as the
nebulizing gas at 60 psi pressure, curtain gas 10 psi, and auxiliary
gas 30 psi. OzID (for determining double bond position) used
entrance to q2 collision energy of 5–10 eV, linear ion trap ﬁll time
of 5 ms, exit collision energy of 8 eV and residence time with ozone
of 2000 ms. COzID (for determining sn-position) used similar MS
parameters except for a modiﬁed q2 collision energy (38–40 eV)
and a residence time with ozone of 250 ms.
2.3.3. Data analysis
®
Spectra were analyzed using PeakView software (SCIEX, Concord, ON, Canada) with an incorporated OzID plug-in, which
allowed for automated annotation of OzID double bond ions. The
plug-in works by highlighting the precursor ion of interest from
which OzIDions were generated, and manual input of the lipid sum
composition into the software (e.g., for [PC 36:1+Na]+ , m/z 810 is
highlighted in the spectrum and PC 36:1 is entered in the software).
The plug-in searches a database of expected OzID neutral losses
and annotates the OzID spectra. Settings concerning the threshold
and mass tolerance are used to ﬁne-tune the assignments, and to
reduce false annotations. The presence of the aldehyde and Criegee
ion pair for each double bond was a requirement for accepting
a positive identiﬁcation. Output was manually curated for correct assignments, and incorrect assignments were removed. An
amended nomenclature for labeling the double bond ions as used
in this manuscript is explained below.
2.3.4. Nomenclature
Lipid structure nomenclature used here is guided by literature
recommendations of Fahy et al. and Liebisch et al.[32,33] with modiﬁcations for the OzID plug-in assignments. Double bond location
in the IUPAC annotation is indicated by a number, counting from
the carboxylic acid end, followed with Z/E indicating cis/trans isomerism. In this work, the site(s) of unsaturation is indicated to be
x-positions from the methyl end by the traditional nomenclature
“n-x”, where “n” refers to the number of carbon atoms in the chain
and subtracting “x” provides the location of the double bond, for
example, PC 18 0/18:2 (9Z,12Z) is represented as PC 18:0/18:2(n6, n-9). This nomenclature is instructive in OzID analysis as the
observed neutral losses are common to all lipids with double bonds
in the sameposition relative tothe highest numbered carbonon the
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alkyl chain [34]. The ozone reaction results in a pair of ions (aldehyde and Criegee) for each double bond [8,13], and using the OzID
plug in, this will be indicated in the assignments as “n-x, aldehyde
or n-x, Criegee”. For double bonds in polyunsaturated fatty acids
(PUFA), there is an additional number added in the assignment for
all bonds except the ﬁrst to indicate their position in the series.
For example: an n-9 double bond in n-3 20:5 PUFA, would be characterized by ions generated from two neutral loss (NL) transitions
(–106 Da and −90Da) [8], and the annotation of the double bond
would be(n-9,3, aldehyde) and (n-9,3, Criegee) respectively, where
(9) indicates the site of unsaturation, (3) indicates that itis the third
double bond in the series from the methyl end after n-3 and n6 double bonds. The ﬁrst double bond in a series has the double
bond site of unsaturation and aldehyde/Criegee. For example,an n3 in the n-3 20:5 PUFA would have two NL transitions (–26 Da and
−10 Da) and is labelled as (n-3, aldehyde) and (n-3 Criegee). Double bonds in monounsaturated fatty acids (MUFA) are labelled the
same as the ﬁrst double bond in a series. The stereochemical conﬁguration of the carbon–carbon double bonds was not determined
and thus is not indicated.
3. Results and discussion
3.1. Examination of targeted lipid ions from direct infusion of a
red blood cell extract
To examine the potential lipid complexity of red blood cells
(RBC), lipid extracts were spiked with sodium acetate and directly
infused into a specialized electrosprayionization triple quadrupole
mass spectrometer operated in positive ion mode. As expected,
abundant ions were observed in the region m/z 650–900 corresponding to ionized phospholipids. Nominal mass of the most
abundant ions in this region were consistent with the [M+Na]+
ions of phosphatidylcholines (PC). Previously described modiﬁcations [12,13] to the instrument enable the addition of ozone (ca.
15% in oxygen) to the collision region and thus the selected ions
were subjected to activation by a combination of collision- and
ozone-induced dissociation (COzID). The resulting product ions
were mass-analyzed by the third quadrupole operating as a linear
ion trap generating a composite spectrum with peaks arising from
both processes. Spectra obtainedfrommass selectionof the m/z 808
and m/z 810 precursor ions from the red blood cell extract using the
COzID approach are shown in Fig. 1(A) and (B), respectively.
Shotgun workﬂows are powerful approaches to lipid structural
assignment. In complex extracts however, they are challenged by
the overlap of multiple lipid isomers and isobars at a given m/z,
confounding the data analysis. The spectrum shown in Fig. 1(A)
reveals a rich fragmentation pattern that results from CID, OzID and
a combination of these processes that provide critical information
as to the structures of different lipid isobars and isomers. Examining the low mass end of the spectrum, product ions are observed
at m/z 147 (loss of C2 H 5 O 4 NaP) [35,36] and m/z 184 (phosphocholine moiety) [37], corresponding to known CID product ions for
PC lipids when ionized in the [M+Na]+ and [M+H]+ forms, respectively. These data indicate the presence of [PC 36:2+Na]+ , and [PC
38:5+H]+ . Exact masses of these ions are 808.5827 and 808.5851
such that resolving power of >300,000 would be required to discriminate between them and co-isolation for tandem mass spectral
analysis is inevitable. Similar CID ions are found in Fig. 1(B) for
m/z 810, indicating the presence of ions originating from both [PC
36:1+Na] + and [PC 38:4+H] + .
3.1.1. Lipid class isobars
Lipids from different classes can also be present at both m/z 808
and 810, which are isobaric on a unit resolutioninstrument and cannot be separated due to the small differences in mass. For example,
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Fig. 1. Direct infusion COzID spectra of RBC lipid extracts. Spectra of (A) m/z 808 dominated by [PC 36:2+Na]+ ions and (B) m/z 810 dominated by [PC 36:1+Na]+ ions. Product
ions facilitating the assignment of a fatty acyl chain to an sn-position in the sodium adduct are shown in bold letters. Product ions arising from the oxidative cleavage of
carbon–carbon double bonds are annotated by a software plug-in with respect to (A) [PC 36:2+Na]+ and (B) [PC 36:1 +Na]+ . Magniﬁcation of these spectra across m/z 620–820
are shown in panels (C) and (D). OzID product ions are annotated with respect to the precursor ions (C) [PC 38:5+H]+ at m/z 808 and (D) [PC 38:4+H]+ at m/z 810.

A.M. Batarseh et al. / International Journal of Mass Spectrometry 431 (2018) 27–36

[PS 36:2+Na]+ (m/z 810.5256) overlaps with [PC 36:1+Na]+ (m/z
810.5983). Previous data indicates PS 36:2 is present in human
RBCs [25] and this is supported by the presence of an ion at m/z 625
(Fig. 1(Band D)) that may have arisen from the loss of the phosphoserine head group (185 Da). Nevertheless, there are no other unique
ions present in this spectrum to permit the unequivocal identiﬁcation of PS36:2 in this RBC lipid extract. If not addressed, this leads
to underestimation of the diversity of the RBC phospholipidome.
3.1.2. sn-Positional isomers
Another challenge faced in direct infusion protocols is the
inability to separate and unambiguously resolve lipid sn-positional
isomerism, i.e., glycerolipid isomers arising from different sites
of substitution of the glycerol backbone. CID of [PC 36:2+Na] +
(m/z 808.5827) produced the [PC 36:2+Na-183] + ion, at m/z 625.5,
which, when allowed to react with ozone for 4000 ms, produced
ions at m/z 407 and 423 (Fig. 1A). These ions can be used to assign
18:0 at sn-1, thus identifying the presence of PC 18:0/18:2 in the
extract [20,21]. The presence of low-abundance ions at m/z 403 and
419 ions, indicate that PC 18:2/18:0 is also present in the RBC lipid
extract. Ions at m/z 379, 405 and 447 are a result of predicted neutral losses and enable the assignment of acyl chains 16:0, 18:1 and
20:2 at the sn-1 position, respectively, in agreement with previous
ﬁndings (supplementary information, Table S3 and S4) [14,20,21]
Taken together, these data indicate the presence of three additional isomers for PC 36:2, i.e., PC 16:0/20:2, PC 20:2/16:0 and PC
18:1/18:1, bringing the total to a minimum of 5 fatty acyl chainand sn-isomers of PC 36:2 in the RBC lipid extract. The same principles canbe applied to interrogating the shotgun spectrum for the
monounsaturated [PC 36:1+Na]+ shown in Fig. 1(B). Similar lipid
isomer and isobars are observed, where [PC 36:1+Na]+ overlaps
with [PC 38:4+H]+ as shown by the diagnostic product ions m/z
147 and 184, respectively (Fig. 1(B)). Product ions at m/z 379, 405
407 and 443 indicate the presence of PC 36:1 isomers with 16:0,
18:1, 18:0 and 20:1 fatty acyl chains at the sn-1 position thus indicating that this lipid population is comprised of a minimum of four
isomers comprised of different acyl chains and sn-positions, i.e., PC
16:0/20:1, PC 20:1/16:0, PC 18:0/18:1 and PC 18:1/18:0. Double
bond positional isomers are also evident as discussed below.
3.1.3. Double bond isomers
OzID ions indicative of double bond position were annotated
using the software plug-in developed for our workﬂow as demonstrated in Fig. 1. The software plug-in is able to assign the double
bond positions for both the sodiated and protonated OzID product
ions. The spectra were analyzed twice, once for sodiated PC 36:2
or PC 36:1, shown in Fig. 1(A) and (B) respectively, and a second
time for protonated PC 38:5 or PC 38:4, shown in Fig. 1(C) and
(D) respectively. Numerous double bond isomers of [PC 36:2+Na] +
(m/z 808) were detected as shown in Fig. 1(A). The ion pair m/z
740 (–68 Da) and 756 (–52 Da) indicate an n-6 double bond, and
an additional pair of ions at m/z 700 (–108 Da) and 716 (–92 Da)
are indicative of an n-9,2 double bond (refer to Table S2 in Supplementary Information). These ions can be assigned to the fatty acyl
chains 18:2(n-6, n-9) or 20:2(n-6, n-9) for [PC 36:2+Na]+ , as previously reported [19,21]. Furthermore, double bond isomers from
monounsaturated fatty acids(MUFA) are identiﬁedby OzID product
ions observed at m/z 698 (–110 Da) and 714 (–94 Da) characteristic
of an n-9 MUFA and m/z 726 (–82 Da) and 742 (–66 Da) ion pair
characteristic of an n-7 MUFA (Table S1 in Supporting Information)
[8,38]. These ions indicate the possibility of at least two, and possibly three double bond isomers namely, PC 18:1(n-9)/18:1(n-9), PC
18:1(n-7)/18:1(n-7) and PC 18:1(n-7) 18:1(n-9).
Fig. 1(C) shows a magniﬁed view of the m/z 610–820 region of
the same spectrum displayed in Fig. 1(A). In this instance however,
it has been reanalyzed with protonated PC 38:5 as the input pre-

31

cursor ion for the OzID plug-in. Notably, a series of aldehyde and
Criegee OzID ion pairs originating from m/z 808, i.e., m/z 782 and
798, m/z 742and 758, m/z 702and 718, m/z 662and 678and m/z 622
and 638 are present. These ions cannot be attributed to any fatty
acyl chains in PC 36:2, but can be attributed to a 20:5(n-3) polyunsaturated fatty acyl chain of protonated PC 18:0/20:5 (OzID neutral
loss transitions are provided in Table S2 in Supporting Information)
[8,19]. It is worth mentioning that the aldehyde ion for the n-6,2
double bond of an n-3 PUFA would overlap with the n-7 Criegee
ion of a MUFA for that same precursor mass in direct infusion protocols, which would complicate the assignment. Evidence for an
n-9 double bond in a MUFA is found in Fig. 1(C) and can originate
from a monounsaturated fatty acyl chain in PC 38:5 or PC 36:2.
The presence of a PC 18:0/20:5 was veriﬁed by COzID of the sodiated adduct in positive mode and CID of the [PC + OAc]− adduct in
negative mode (data not shown).

3.2. Optimization of LC-OzID/COzID workﬂow
Fig. 1 demonstrates some of the challenges in obtaining unambiguous structural information on lipids derived from complex
biological extracts using a direct infusion COzID approach. To
maximise the lipid structural information that can be derived,
we investigated the advantages of incorporating LC separation to
reduce the complexity. To best match the instrument duty cycle
for the LC workﬂow, we developed two sets of instrument conditions to enhance the abundance of structural diagnostic ion
populations for double bond position (OzID) and for sn-position
(COzID). Optimization of ozone reactiontimes to generate diagnostic ions on a chromatographic time scale and acquiring sufﬁcient
data points across the chromatographic peak was required. The
result was to undertake two sample injections in series using the
same RP-UHPLC methodbut operating the MS with optimized protocols for OzID and COzID, respectively. The experiments were
ﬁrst optimized on commercially available synthetic lipids with
representative data shown in Figs. 2 and 3. Fig. 2(A) shows an
LC chromatogram obtained from injecting an equimolar solution
of the three synthetic phosphatidylcholine isomers, PC 18:1(n9)/18:1(n-9), PC 18:1(n-12)/18:1(n-12) and PC 18:0/18:2(n-6, n-9),
onto a reversed-phase C 30-column with the addition of sodium
acetate post-column. OzID spectra for the selected precursor ions at
m/z 808 were obtained with a ∼2000 ms residence time in the collision cell. The total ion chromatogram (TIC) constructed from the
abundance of all ions detected in OzID scans is shown in Fig. 2(A)
revealing two baseline resolved chromatographic features with
peak maxima at 23.3 and 25.0 mins.
The extracted-ion chromatograms (XICs) shown in Fig. 2(B)
were obtained using product ions diagnostic for different double bond positions namely, m/z 698 (–110 Da, n-9) labelled peak
1, and m/z 656 (–152 Da, n-12) and m/z 740 (–68 Da, n-6) both
labelled as peak 2 since they are not fully resolved. In agreement
with previous ﬁndings, PC 18:1(n-9)/18:1(n-9) eluted before PC
18:1(n-12)/18:1(n-12) [19,21]. Although the second feature contains two co-eluting isomers that are not chromatographically
resolved, the unique OzIDproduct ions for (n-12) and (n-6) double
bonds, allowed generation of distinct XICs that clearly identiﬁed
the presence of the two isomers. OzID spectra obtained from integration across chromatographic peaks 1 and 2 (Fig. 2B) are shown
in Fig. 2(C) and (D), respectively. Product ions at m/z 698 and 714
dominate the spectrum obtained from the ions eluting at peak 1
(Fig. 2C). These ions are diagnostic for an n-9 double bond and conﬁrm PC 18:1(n-9)/18:1(n-9) as the lipid eluting at 23.3 min. The
integrated spectrum obtained from the second peak (Fig. 2D) contains three pairs of product ions, m/z 740 and 756 and m/z 700 and
716 that can be assigned to PC 18:0/18:2(n-6, n-9) as well as an ion
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Fig. 2. (A) UHPLC-OzID chromatogram of a 5 L injection of a mixture of synthetic phosphatidylcholine isomers PC 18:1(n-9)/18:1(n-9), PC 18:1(n-12)/18:1(n-12) and PC
18:0/18:2(n-6,9). Total ion current for m/z 808 [PC 36:2+Na]+ precursor ions shows two chromatographic features. (B) XICs are shown for OzID product ions from oxidative
cleavage of n-9 double bond (blue trace) peak #1, two overlapping peaks n-6 (pink trace) and n-12 (red trace) double bonds, both in peak 2, (expanded in inset). Average
OzID mass spectra of the chromatographic features between (C) 23.00-23.69 mins (peak 1) and (D) 24.72-25.33 mins (Peak 2) are shown, and OzID ions for double bonds are
annotated using the softwareplug in. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)

Fig. 3. (A) UHPLC-COzID chromatogram of a 5 L injection of a mixture of synthetic PC 18:1(n-9)/18:0 and PC 18:0/18:1(n-9) isomers. Total ion current for m/z 810 [PC
36:1+Na]+ precursor ions shows one chromatographic feature. (B) XICs for CID ion at m/z 147 (red trace) and COzID diagnostic product ions corresponding to 18:1at sn–1 m/z
405 ion (blue trace), and 18:0 at sn–1 m/z 407 ion (pink trace), expanded in inset. COzID mass spectra obtained by averaging between(C) 25.37-25.51 mins and (D) 25.82-26.00
mins are shown. Annotations of sn-positions are shown in bold letters. Insets in (C) and(D) highlight the different ratios in abundance of m/z 405 and 407 ionsat the beginning
of the chromatographic peak versus the end. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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Fig. 4. (A) UHPLC-COzID analysis targeting ions at m/z 808 from generated from a 5L injection of red blood cell lipid extract. XICs for CID ions m/z 147 (blue trace) and 603
[PC 36:2-Na-183]+ (pink trace) show three chromatographic features (see magniﬁcation inset). COzID mass spectra were obtained by integrating between (B) 21.10-21.46
mins, (C) 22.30-22.45 mins and (D) 22.57-22.86 mins. Bold labels show sn-1 assignments. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)

pair at m/z 656 and 672 that correspond to an n-12 double bond
that can be assigned to PC 18:1(n-12)/18:1(n-12).
Fig. 3 shows the data obtained from an equimolar mixture of
synthetic PC 18:0/18:1(n-9) and PC 18:1(n-9)/18:0. In these experiments the ﬁrst quadrupole of the MS was set to transmit ions
at m/z 810 that were then subjected to conditions optimized for
COzID. The TIC of the precursor ion signal at m/z 810 is shown
in Fig. 3(A), and reveals a single feature with a maximum at 25.7
mins but with a subtle peak shoulder at ca. 25.5 mins. The chromatogram in Fig. 3(B) plots the XICs obtained from the COzID
product ions m/z 405 (assigning 18:1 to the sn-1 position) and
m/z 407 (assigning 18:0 to the sn-1 position). Close inspection of
these XICs reveals two partially separated peaks with PC 18:1/18:0
eluting slightly earlier than PC 18:0/18:1 (see Fig. 3B, inset). Integrating the spectra obtained at the beginning of the peak (blue
box; RT 25.37-25.51 mins) and towards the end of the peak (pink
box; RT 25.82-26.00 mins) produces the spectra shown in Fig. 3C
and D, respectively. Two COzID product ion pairs at m/z 405 and
421 and m/z 407 and 423 are present in both spectra and indicate
both 18:1 and 18:0 at the sn-1 position, respectively. Product ions
indicative of an 18:1 at sn-1 are higher in abundance in Fig. 3(C),
while product ions indicative of an 18:0 at sn-1 are higher in
Fig. 3(D) (see insets). Therefore, COzID ion ratios conﬁrm that PC
18:0/18:1 elutes just prior to PC 18:1/18:0 indicative of partial separation of these sn-positional isomers on the C30 -reversed phase
column.

3.3. LC-COzID and LC-OzID of RBC lipid extracts
3.3.1. Resolving sn-positional isomers
Data presented in Fig. 4 were acquired by loading 5 L of RBC
lipid extract onto a C30 -column and introducing the eluent into the
MS through an ESI source operated in positive mode. Data were
acquired by mass-selecting ions of m/z 808, activating them with a
collision energy of 38–40 eV, and trapping both precursor ions and
CID products in the presence of ozone for 250 ms yielding COzID
mass spectra. The XIC of the m/z 147 and 603 product ions, that
are characteristic of sodiated PC, are shown in Fig. 4(A) and reveal
three peaks with maxima at 21.3, 22.3 and 22.7 mins (see inset).
Mass spectra obtained by integrating across each of these three
peaks are presented in Fig. 4(B)–(D) and show the expected CID
product ions at m/z 749 (loss of trimethylamine) and 603 (loss of a
sodiated PC headgroup) conﬁrming the identity of each as a phosphatidylcholine. The spectrum obtained from the peak at 21.3 mins
(Fig. 4B) shows a single COzID ion pair m/z 405 and 421 characteristic of 18:1 at sn-1, and can thus be attributed to PC 18:1/18:1.
The second chromatographic feature at 22.3 mins (Fig.4C) contains
COzID ions at m/z 379and 395 indicative of 16:0at sn-1 and m/z 301
and 317 revealing the presence of 20:2 at sn-2 and thus identiﬁes
PC 16:0/20:2 (see Tables S3 and S4 in Supporting Information). The
COzID spectrum obtained from the third chromatographic feature
at 22.7 mins contains ions at m/z 407 and 423 identifying 18:0 at
sn-1 as well as lower abundance m/z 403 and 419 ions characteristic of 18:2 at sn-1. Taken together, these ions indicate the presence
of at least four isomers for PC 36:2; PC 18:1/18:1, PC 16:0/20:2,
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Fig. 5. (A) UHPLC-OzID chromatogram targeting ions at m/z 808 from generated
from a 5 L injection of red blood cell extract. [PC 36:2 + Na]+ chromatogram is
visualized using XIC for OzID product ions from oxidative cleavage of n-9 (blue
trace), n-7(pink trace), n-9,2 (red trace) and n-6 (green trace) double bonds, showing
multiple features. OzID mass spectra corresponding to chromatographic features
between (B) 21.78-22.64 mins and (C) 23.00–24.15 mins are shown. OzID-ion pairs
for double bonds are annotated using the custom PeakView software plug in. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred
to the web version of this article.)

PC 18:0/18:2 and PC 18:2/18:0. Similar to the PC 36:2 standards,
PC 18:1/18:1 is chromatographically resolved from PC 18:0/18:2
in RBC lipid extracts, which simpliﬁes the structural analysis by
interrogating each chromatographic peak independently.
3.3.2. Resolving double bond positional isomers
Further analysis of the same population of phosphatidylcholine
isomers was undertaken using identical chromatographic conditions but modifying the mass spectrometric conditions for
ampliﬁcationof signals related to carbon–carbon doublebond location. In these experiments the m/z 808 ions from RBC lipid extracts
were mass-selected and delivered to the second quadrupole with
lower collision energy (5–10 eV) with subsequent trapping of the
ions with ozone for 2000 ms yielding mass spectra with a greater
proportion of OzID product ions. Fig. 5 shows representative data
acquired under these LC-OzID conditions. XICs of ions diagnostic of PC 36:2 double bond positions are shown in Fig. 5(A) and
reveal two main features with maxima at ca. 22.4 and 23.4 mins.
OzID product ions obtained from the ions eluting at 22.4 mins are
observed at m/z 698 and 714 in Fig. 5B and correspond to neutral losses of 110 and 94 expected for an n-9 double bond. An
additional ion pair at m/z 726 and 742 corresponding to neutral
losses of 82 Da and 66 Da, respectively identify the presence of an
n-7 double bond. When these data are taken together with the
LC-COzID results (see above) they suggest at least two, but up to

four possible PC 18:1 18:1 isomers are present in the RBC extract,
namely, PC 18:1(n-9)/18:1(n-9), PC18:1(n-7)/18:1(n-7), PC18:1(n9)/18:1(n-7) and PC 18:1(n-7)/18:1(n-9). Recent work from our
group reported the existence of these same four isomers in egg yolk
extract, where despite not being separated chromatographically,
they were identiﬁed using OzID ions [21]. It should be noted that
elution of these PC 36:2 species is centered at 22.4 mins in the LCOzID analysis (Fig. 5A) but the corresponding feature has a maxima
at 21.3 min in the LC-COzID analysis (Fig. 4A). This shift in retention
time is a consequence of experiments being conducted on different days as there is no shift in retention time when LC-COzID and
LC-OzID experiments run on the same day (cf. Fig. 4A and Fig. S1A).
Regardless, the ﬁdelity of retention time is maintained and therefore such shifts do not limit the current analysis. When increasing
the througput of this workﬂow however, retention time alignment
protocols could be implemented to simplify data analysis.
The integrated OzID spectrum produced from the ions eluting
at ca. 23.4 mins (Fig. 5C) contains two pairs of product ions at m/z
740 and 756 as well as m/z 700 and 716 that identify n-6 and n-9
double bonds on a common, polyunsaturated acyl chain. Based on
information in both LC-OzID and LC-COzID experiments these ions
can be attributed to PC 18:0/18:2(n-6, n-9), PC 18:2(n-6, n-9)/18:0
and PC 16:0/20:2(n-6, n-9). While the co-elution of these species
means that the OzID spectrum shown in 5(C) represents a composite of the two acyl chain isomers (PC 18:0 18:2 and PC 16:0 20:2)
the clear pattern of OzID product ions indicate that both species
have identical unsaturation relative to the methyl termini of their
respective acyl chains. The presence of both (n-6) speciesis consistent with elongation of diet derived 18:2(n-6) to form 20:2(n-6) in
accordance with known metabolic pathways in humans. 39 Overall, the combination of LC-OzID and LC-COzID analysis identiﬁes up
to seven PC 36:2 isomers in RBC lipid extracts. The acquisition of
the data in an LC-workﬂow dramatically reduced the spectral complexity (cf. direct infusion data in Fig. 1) and lessened the ambiguity
in structural assignments.
3.3.3. Resolving lipid adduction isobars
Another advantage of introducing LC separation is reducing
sample complexity by resolving adduct ion isobars. Analysis of LCCOzID data from red blood cell extracts obtained at m/z 808 and
810 revealed multiple features corresponding to isobars of different lipid composition. Representative data shown in Fig. 6 show
the separate elution of different phosphatidylcholines that, when
adducted with a proton or a sodium share a common precursor
ion nominal mass. For example, [PC 38:5+H]+ and [PC 36:2+Na]+
at m/z 808.5 (Fig. 6A), and [PC 38:4+H]+ and [PC 36:1+Na]+ at m/z
810.5 (Fig. 6B) show clearly distinct retention time proﬁles. The
XICs obtained from m/z 184 (produced by CID of protonated PC)
and m/z 147 (produced by CID of sodiated PC) are shown in Fig. 6
and clearly demonstrate the separation of these lipids. The multiple
features observed in the m/z 184XICs are consistent with previous
data identifying a range of isomers present for PC 38:5and PC 38:4
[23,25,27,40].
3.3.4. Resolving lipid class isobars
Chromatographic separation of RBC lipid extracts also removed
isobaric interference arising from different phospholipid classes,
e.g., [PC 38:3+Na]+ and [PS 38:4+Na]+ (m/z 834) as shown in
Fig. 7(A). These data further serve to illustrate the ability of the
COzID protocol to generate structural informative spectra from
a complex lipid extract for PS lipids on a chromatographic time
scale. The XIC of m/z 627 and 629 ions representing the loss of the
sodiated headgroups from PS 38:4 and PC 38:3, respectively, were
usedto visualize the chromatographic features related to each lipid.
Integration of the mass spectral data across both chromatographic
features produced the COzID spectra shown in Fig. 7(B) and (C).
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Fig. 6. UHPLC-COzID chromatograms for precursor ions of m/z 808 and 810 visualized using CID product ions m/z 184 andm/z 147 and show the resolution of isobaric
overlap originatingfrom different PC adductions. (A) [PC38:5 +H] + is separatedfrom
[PC 36:2 +Na] + and (B) [PC 38:4 +H] + is separated from [PC 36:1 +Na] + reducing
interference seen in direct infusion analysis.

Fig. 7. (A) UHPLC-COzID chromatogram of a 5 L injection of red blood cell extract
trapping for m/z 834 ions. LC allowed separation of PS 38:4 from its isobaric PC
38:3 m/z 834 into different chromatographic features. XICs of CID product ions
indicative of the loss of the sodiated phosphoserine headgroup m/z 627 (blue trace)
vsm/z 627(pink trace), whichis diagnostic of the loss of the sodiatedphosphocholine
moiety. COzID mass spectra of the integrated chromatographicfeatures between (B)
17.13-18.29 mins and (C) 23.22-23.5 mins are shown. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of
this article.)
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For the low mass ion in these spectra (m/z < 250), a slight mass
shift is observed indicating poor mass calibration in this region.
Nonetheless, ions m/z 146 and m/z 207 can be assigned as m/z 147
(C 2 H5 O4 NaP) [35,36] and m/z 208 (sodiated phosphoserine moiety [Phosphoserine+Na]+ ) [41], respectively and are indicative of
the PS moiety. A loss of the serine moiety (–87 Da C3 H 5 NO 2 ) [41]
at m/z 747 is also observed, conﬁrming the presence of a PS in this
chromatographic feature. The COzID spectrum shown in Fig. 7(B)
contains ions indicative of the presence of 18:0 at sn-1 (m/z 407 and
423) and 20:4 at sn-2 (m/z 297 and 313) that identify PS 18:0/20:4
the most abundant isomer eluting at ca. 17.8 min (see Supplementary Information, Table S4). In Fig. 7C, ions at m/z 775 and 629
represent neutral losses of 59 and 183Da, respectively, that are
indicative of a sodiated phosphatidylcholines [42] and conﬁrm the
presence of PC 38:3. COzID ions identify 18:0 at sn-1 (m/z 407 and
423) and 20:3 at sn-2 (m/z 299 and 315) further elucidating the
identity of the lipid eluting at ca. 23.5 min as PC 18:0/20:3 (see
Supporting Information, Tables S3 and S4). Notably, the signal-tonoise ratio is reduced for lower abundance lipid species (Fig. 7A) in
contrast to high abundance lipids (Fig. 4A), however, thesensitivity
of this workﬂow is demonstrated by its ability to generate COzID
spectra capableof providing structural information for both PS and
PC species (Fig. 7B and C). When combined with OzID analysis, the
ion at m/z 834 can be identiﬁed as a cluster of isobars, i.e., PC 38:3
and PS 38:4, and their respective double bond- and sn-positional
isomers, speciﬁcally PC 18:0/20:3(n-6), PS 18:0/20:4(n-6) and PS
20:4(n-6)/18:0. This structural elucidation would have been difﬁcult to ascertain for a complex lipid extract without LC separation.

4. Conclusions
The complexity of even ostensibly simple lipidomes, such as the
human RBC analyzed here, results in the co-isolation of numerous
lipids within the 1 Th isolation window afforded by modern mass
spectrometers when utilising a shotgun approach. The resulting
OzID spectra therefore contain fragment ions from each of the isolated lipids, complicating spectral interpretation. While combining
CID and OzID is effective in obtainingnear completestructural identiﬁcation of phospholipids14 it can further complicate spectra and
impair the ability to identifylow-abundance lipids.Here we present
a new workﬂow utilising RP-UPLC to maximise isomer and isobar
separation in combination with a 2-stage OzID and COzID protocol.
This approach utilises serial LC runs with MS parameters optimized
for either double bond ions (OzID) or sn-substitution ions (COzID)
that are relatable, even with shifts in retention time. We were also
able to reduce OzID reaction times allowing sufﬁcient data within
the LC timeframe. Additionally, a plug-in for PeakviewTM software
providing automated annotation of OzID spectra has been developed.
Application of this workﬂow to lipid extracts from human RBCs
has providednew insightinto the phospholipids present. For example, traditional CID of ions observed at m/z 834 in positive ion
mode in a direct infusion experiment identiﬁes the presence of
both PC 38:3 and PS 38:4 as sodium adducts. The key diagnostic CID/OzID ions produced from these lipids are identical making
it difﬁcult to obtain a deﬁnitive structural characterization. The
UPLC-OzID/COzID workﬂow allowed the unequivocal identiﬁcation of PC 18:0/20:3(n-6), PS 18:0/20:4(n-6) and PS 20:4(n-6)/18:0,
which wasnot possible using adirect injection approach.While the
approach described here is not yet applicable to analysis of all lipids
in a single high-throughput experimentit does allow detailed structure analysis of phospholipids, even at low concentration and can
be applied across different lipid classes and tissues to provide the
next step towards complete characterization of all phospholipids
within complex lipidomes.
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